Results 121 to 130 of about 3,177,228 (297)

Regional differences in global glacier retreat from 1980 to 2015

open access: yesAdvances in Climate Change Research, 2019
Global warming triggers shrinking and thinning of glaciers worldwide, with potentially severe implications for human society. However, regional differences in glacier retreat and its relationship with climatic characteristics have not been conclusively ...
Yao-Jun Li   +3 more
doaj   +1 more source

The Shaping of the Red Rectangle Proto-Planetary Nebula

open access: yes, 2004
I argue that the slowly expanding biconical structure of the Red Rectangle--a nebula around the post asymptotic giant branch binary stellar system HD 44179--can be formed by intermittent jets blown by the accreting companion.
Soker, Noam
core   +2 more sources

New theoretical Mass-loss rates of O and B Stars

open access: yesAstronomy & Astrophysics, 2000
Accepted by A&A, 16 pages Latex, 11 ...
Vink, J.S.   +2 more
openaire   +3 more sources

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

open access: yesMolecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken   +7 more
wiley   +1 more source

Continuum driven winds from super-Eddington stars. A tale of two limits

open access: yes, 2007
Continuum driving is an effective method to drive a strong stellar wind. It is governed by two limits: the Eddington limit and the photon-tiring limit. A star must exceed the effective Eddington limit for continuum driving to overcome the stellar gravity.
Owocki, S. P.   +2 more
core   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Numerical analysis of Eucalyptus grandis × E. urophylla heat-treatment: A dynamically detecting method of mass loss during the process

open access: yesResults in Physics, 2017
Eucalyptus particles, lamellas and boards were applied to explore a simply-implemented method with neglected heat and mass transfer to inspect the mass loss during the heat-treatment course. The results revealed that the mass loss of a certain period was
Zijian Zhao   +4 more
doaj   +1 more source

Masses of Classical Cepheids and Mass Loss Rate at Pre-Cepheid Stage [PDF]

open access: yesInternational Astronomical Union Colloquium, 1977
The mass-luminosity relation for single-mode Cepheids obtained by Saio, Kobayashi, and Takeuti (1977) indicates that the masses of classical Cepheids seem to be less than those that result from evolutionary calculations without substantial mass loss. The mass loss rate at the red giant phase should be 10−5 solar masses per year.
openaire   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy